Skip to main content
. 2014 Dec 24;16:S635–S716. doi: 10.1111/j.1469-0691.2010.03240.x

Table 1.

Overview of results of CMV IgG and IgM determinations of 71 selected patient samples by Roche (Modular), Beckman Coulter (Access), Siemens (Immulite) and bioMérieux (Vidas)

CMV IgG (U/ml)
Modular Access
Immulite
Vidas
<11 11–<15 15–<30 ≥30 <0.9 0.9–<1.0 ≥1.0–<2.0 ≥2.0 <4 ≥4–<6 ≥6–<12 ≥12
<0.5 17 1 0 1 14 1 3 1 8 6 5 0 19
0.5–1.0 3 0 1 0 2 0 1 1 1 1 2 0 4
≥1.0–<2.0 1 0 1 0 1 0 0 1 0 2 0 0 2
≥2.0 1 2 3 40 7 1 6 32 1 2 10 33 46
22 3 5 41 24 2 10 35 10 11 17 33 71
CMV IgM (cut-off index)
Modular Access
Immulite
Vidas
<0.8 0.8–<1.0 1.0–<2.0 ≥2.0 <0.9 0.9–<1.0 ≥1.0–<2.0 ≥2.0 <0.7 ≥0.7–<0.9 ≥0.9–<1.8 ≥1.8
<0.7 28 4 2 1 21 2 4 8 20 11 2 2 35
≥0.7–<1.0 2 1 3 1 2 0 2 3 0 1 3 3 7
≥1.0–<2.0 2 1 0 5 2 0 0 6 0 3 1 4 8
≥2.0 1 0 3 17 2 0 3 16 0 0 7 14 21
33 6 8 24 27 2 9 33 20 15 13 23 71